Home > Healthcare > Medical Devices > Therapeutic Devices > Vascular Closure Device Market

Vascular Closure Device Market Trends

Report ID: GMI1967
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Vascular Closure Device Market Trends

Several technical breakthroughs to increase the efficacy of vascular closure devices for enhanced safety and patient comfort will accelerate the market demand. The demand for biodegradable closure devices has gained widespread popularity due to their composition of biodegradable materials and gradual disintegration for natural healing. Furthermore, the growing demand for topical hemostatic medicines in conjunction with closure devices to improve hemostasis will drive the market expansion.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Vascular closure devices industry was valued at USD 1.5 billion in 2022 and is poised to depict 6.5% CAGR from 2023 to 2032 owing to the increasing number of patients suffering from cardiovascular diseases worldwide.

Active segment is expected to witness tremendous growth and reach USD 1.8 billion by 2032 due to the rising preference for minimally invasive procedures in interventional radiology and cardiology.

North America vascular closure device market size generated more than USD 689 million in revenue in 2022 and is estimated to witness notable CAGR from 2023-2032 owing to the increasing prevalence of cardiovascular illnesses and the availability of advanced healthcare infrastructure.

Some of the key vascular closure device companies include Scion BioMedical, Abbott, Terumo Corporation, Cardinal Health, Inc., Medtronic, plc, Teleflex Incorporated, TZ Medical, Tricol Biomedical, Cardiva Medical Inc., and Marine Polymer Technologies.